Drug Trial Radar · NCT03627130
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
Last checked: Nov 19, 2026Latest source record: Dec 16, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
640
Actual
Start
Nov 29, 2018
Primary completion
May 30, 2022
Study completion May 30, 2022
Sponsor
- Lead sponsor
- Barts & The London NHS TrustAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 13, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Contrast-induced nephropathy (CIN), an acute kidney injury resulting from the administration of intravascular iodinated contrast media, is an important cause of morbidity/mortality following coronary angiographic procedures in high-risk patients. Despite preventative measures intended to mitigate the risk of CIN, there remains a need for an effective intervention. Dietary inorganic nitrate therapy, which through its chemical reduction in the body delivers nitric oxide has shown promise in attenuating CIN, but its effectiveness in preserving long-term renal function is unknown.
Conditions
- Contrast-induced Nephropathy
- Acute Kidney Injury
- Acute Coronary Syndrome
Interventions
Potassium NitrateDrug
Potassium nitrate capsules (KNO3: 12 mmol giving 744 mg of nitrate) for 5 days
Potassium ChlorideDrug
Potassium Chloride capsules for 5 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Contrast Induced NephropathyTime frame: 48-72 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Barts Heart Centre
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.